Posted on Friday 25 April 2014

Some references about the Zohydro controversy [a big mistake…]…
hat tip to jamzo…  
    April 26, 2014 | 8:52 AM
    Steve Lucas
    April 26, 2014 | 11:28 AM

    This is what happens when pharma is allowed to push its message of a pill for every person and every person taking a pill. Decades ago I was warned that salesmen want to sell and they do not care what they sell. This is how they get their job rush.

    This drug will be no different.

    Steve Lucas

    April 26, 2014 | 6:38 PM

    It’s not a pill for every person, it’s a pill for every symptom.

    Steve Lucas
    April 26, 2014 | 11:09 PM

    I stand corrected.

    Steve Lucas

    James O'Brien, M.D.
    April 27, 2014 | 11:40 AM

    I don’t like this at all. The SEC is in a partnership with investment banks. We know how that works out.

    On the other hand, it shouldn’t take 1.5 billion dollars and 15 years to get a drug approved.

    New treatments that are not me too drugs should be approved after a safety trial and let the clinicians argue about efficacy.

Sorry, the comment form is closed at this time.